[go: up one dir, main page]

HK1233927A1 - Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use - Google Patents

Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use Download PDF

Info

Publication number
HK1233927A1
HK1233927A1 HK17107610.6A HK17107610A HK1233927A1 HK 1233927 A1 HK1233927 A1 HK 1233927A1 HK 17107610 A HK17107610 A HK 17107610A HK 1233927 A1 HK1233927 A1 HK 1233927A1
Authority
HK
Hong Kong
Prior art keywords
preparation
pan
processes
methods
kinase inhibitor
Prior art date
Application number
HK17107610.6A
Other languages
Chinese (zh)
Inventor
L. Brake Rachael
Bozon Viviana
J. Chow Ching-Kuo
C. Dinunzio James
M. Galvin Katherine
Kannan Karuppiah
Kodono Yuki
Xu Qunli
Original Assignee
Millennium Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals, Inc. filed Critical Millennium Pharmaceuticals, Inc.
Publication of HK1233927A1 publication Critical patent/HK1233927A1/en

Links

Abstract

The invention relates to a pharmaceutical composition comprising Compound 1 or a pharmaceutically acceptable salt thereof for the treatment of cancer and a process for its preparation. The invention also relates to administering the pharmaceutical composition to a patient according to an intermittent dosing regimen.
HK17107610.6A 2014-03-26 2015-03-26 Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use HK1233927A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201461970595P 2014-03-26
US201462048527P 2014-09-10
UY20150036046 2015-03-25
PK20150016220 2015-03-25

Publications (1)

Publication Number Publication Date
HK1233927A1 true HK1233927A1 (en) 2018-02-09

Family

ID=

Similar Documents

Publication Publication Date Title
MA39765A (en) Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use
MX2022001755A (en) Cyclic di-nucleotide compounds and methods of use.
NZ762034A (en) Human plasma kallikrein inhibitors
EA033544B1 (en) Pyridone derivatives as rearranged during transfection (ret) kinase inhibitors
EA033266B1 (en) Hydroxyester derivatives, process for their preparation and pharmaceutical compositions containing them
TW201613864A (en) Novel compounds
HK1217092A1 (en) Therapeutic compounds and uses thereof
TW201613578A (en) Pharmaceutical combinations
PH12016502352A1 (en) Pharmaceutical composition
WO2015173701A3 (en) Pharmaceutical compositions comprising danirixin for treating infectious diseases
MX376029B (en) Isoindole compounds
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
WO2015001541A3 (en) Pharmaceutical film composition
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
WO2016112304A8 (en) Furoquinolinediones as inhibitors of tdp2
MX2017002544A (en) Isoquinolinone derivatives useful in the treatment of cancer.
MX2016017315A (en) Pharmaceutical dosage forms.
HK1233927A1 (en) Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use
IL262490A (en) Complexes of lumacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
IL262489A (en) Complexes of ivacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
WO2018084817A3 (en) A new form of active agent
HK40005617A (en) Complexes of lumacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HK40005618A (en) Complexes of ivacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HK1217191A1 (en) Therapeutic compounds and uses thereof